Jelena Djordjevic

Jelena Djordjevic

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TSTijana Srdić
Tijana Srdić
SĐSiniša Đurašević
Siniša Đurašević
ILIva Lakic
Iva Lakic
ARAleksandra Ružičić
Aleksandra Ružičić
PVPredrag Vujovic
Predrag Vujovic
Nebojša JasnićNebojša Jasnić
Nebojša Jasnić
Sepsis-induced multiple organ dysfunction arises from the highly complex pathophysiology encompassing the interplay of inflammation, oxidative stress, endothelial dysfunction, mitochondrial damage, cellular energy failure, and dysbiosis. Over the past decades, numerous studies have been dedicated to elucidating the underlying molecular mechanisms of sepsis in order to develop effective treatments. Current research underscores liver and cardiac dysfunction, along with acute lung and kidney injuries, as predominant causes of mortality in sepsis patients. This understanding of sepsis-induced organ failure unveils potential therapeutic targets for sepsis treatment. Various novel therapeutics, including melatonin, metformin, palmitoylethanolamide (PEA), certain herbal extracts, and gut microbiota modulators, have demonstrated efficacy in different sepsis models. In recent years, the research focus has shifted from anti-inflammatory and antioxidative agents to exploring the modulation of energy metabolism and gut microbiota in sepsis. These approaches have shown a significant impact in preventing multiple organ damage and mortality in various animal sepsis models but require further clinical investigation. The accumulation of this knowledge enriches our understanding of sepsis and is anticipated to facilitate the development of effective therapeutic strategies in the future.

Verified
Journal Article
Open access
PDF file
TDTamara Dakic
Tamara Dakic
TJTanja Jevdjovic
Tanja Jevdjovic
ILIva Lakic
Iva Lakic
ARAleksandra Ružičić
Aleksandra Ružičić
Nebojša JasnićNebojša Jasnić
Nebojša Jasnić
PVPredrag Vujovic
Predrag Vujovic
After being discovered over a century ago, insulin was long considered to be a hormone exclusively produced by the pancreas. Insulin presence was later discovered in the brain, which was originally accounted for by its transport across the blood-brain barrier. Considering that both insulin mRNA and insulin were detected in the central nervous system (CNS), it is now known that this hormone is also synthesized in several brain regions, including the hypothalamus, hippocampus, cerebral and cerebellar cortex, and olfactory bulb. Although many roles of insulin in the CNS have been described, it was initially unknown which of them could be attributed to brain-derived and which to pancreatic insulin or whether their actions in the brain overlap. However, more and more studies have been emerging lately, focusing solely on the roles of brain-derived insulin. The aim of this review was to present the latest findings on the roles of brain-derived insulin, including neuroprotection, control of growth hormone secretion, and regulation of appetite and neuronal glucose uptake. Lastly, the impairment of signaling initiated by brain-derived insulin was addressed in regard to memory decline in humans.

22 July 2014 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
KATARINA SMILJANICKATARINA SMILJANIC
KATARINA SMILJANIC
MOMilan Obradovic
Milan Obradovic
AJAleksandra Jovanovic
Aleksandra Jovanovic
JDJelena Djordjevic
Jelena Djordjevic
BDBranislava Dobutovic
Branislava Dobutovic
EIEsma Isenovic
Esma Isenovic

Verified
Journal Article
Open access
PDF file
SĐSiniša Đurašević
Siniša Đurašević
Maja StojkovicMaja Stojkovic
Maja Stojkovic
LBLjiljana Bogdanović
Ljiljana Bogdanović
Sladjan PavlovicSladjan Pavlovic
Sladjan Pavlovic
Slavica Borković-MitićSlavica Borković-Mitić
Slavica Borković-Mitić
Zoran TodorovicZoran Todorovic
Zoran Todorovic
Acute renal ischemia/reperfusion (I/R) injury is a clinical condition that is challenging to treat. Meldonium is an anti-ischemic agent that shifts energy production from fatty acid oxidation to less oxygen-consuming glycolysis. Thus, in this study we investigated the effects of a four-week meldonium pre-treatment (300 mg/kg b.m./day) on acute renal I/R in male rats (Wistar strain). Our results showed that meldonium decreased animal body mass gain, food and water intake, and carnitine, glucose, and lactic acid kidney content. In kidneys of animals subjected to I/R, meldonium increased phosphorylation of mitogen-activated protein kinase p38 and protein kinase B, and increased the expression of nuclear factor erythroid 2-related factor 2 and haeme oxygenase 1, causing manganese superoxide dismutase expression and activity to increase, as well as lipid peroxidation, cooper-zinc superoxide dismutase, glutathione peroxidase, and glutathione reductase activities to decrease. By decreasing the kidney Bax/Bcl2 expression ratio and kidney and serum high mobility group box 1 protein content, meldonium reduced apoptotic and necrotic events in I/R, as confirmed by kidney histology. Meldonium increased adrenal noradrenaline content and serum, adrenal, hepatic, and renal ascorbic/dehydroascorbic acid ratio, which caused complex changes in renal lipidomics. Taken together, our results have confirmed that meldonium pre-treatment protects against I/R-induced oxidative stress and apoptosis/necrosis.

Verified
Journal Article
Open access
PDF file
NĐNina Đukanović
Nina Đukanović
SOSlobodan Obradovic
Slobodan Obradovic
Marija ZdravkovićMarija Zdravković
Marija Zdravković
SĐSiniša Đurašević
Siniša Đurašević
Maja StojkovicMaja Stojkovic
Maja Stojkovic
Zoran TodorovicZoran Todorovic
Zoran Todorovic
Lipids play an essential role in platelet functions. It is known that polyunsaturated fatty acids play a role in increasing platelet reactivity and that the prothrombotic phenotype plays a crucial role in the occurrence of major adverse cardiovascular events. The ongoing increase in cardiovascular diseases’ incidence emphasizes the importance of research linking lipids and platelet function. In particular, the rebound phenomenon that accompanies discontinuation of clopidogrel in patients receiving dual antiplatelet therapy has been associated with changes in the lipid profile. Our many years of research underline the importance of reduced HDL values for the risk of such a rebound effect and the occurrence of thromboembolic events. Lipids are otherwise a heterogeneous group of molecules, and their signaling molecules are not deposited but formed “on-demand” in the cell. On the other hand, exosomes transmit lipid signals between cells, and the profile of such changes can be monitored by lipidomics. Changes in the lipid profile are organ-specific and may indicate new drug action targets.

4 June 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
SĐSiniša Đurašević
Siniša Đurašević
SPSnezana Pejic
Snezana Pejic
IGIlijana Grigorov
Ilijana Grigorov
GNGorana Nikolić
Gorana Nikolić
DMDragana Mitić-Ćulafić
Dragana Mitić-Ćulafić
Zoran TodorovicZoran Todorovic
Zoran Todorovic
Thioacetamide (TAA) is widely used to study liver toxicity accompanied by oxidative stress, inflammation, cell necrosis, fibrosis, cholestasis, and hepatocellular carcinoma. As an efficient free radical’s scavenger, C60 fullerene is considered a potential liver-protective agent in chemically-induced liver injury. In the present work, we examined the hepatoprotective effects of two C60 doses dissolved in virgin olive oil against TAA-induced hepatotoxicity in rats. We showed that TAA-induced increase in liver oxidative stress, judged by the changes in the activities of SOD, CAT, GPx, GR, GST, the content of GSH and 4-HNE, and expression of HO-1, MnSOD, and CuZnSOD, was more effectively ameliorated with a lower C60 dose. Improvement in liver antioxidative status caused by C60 was accompanied by a decrease in liver HMGB1 expression and an increase in nuclear Nrf2/NF-κB p65 ratio, suggesting a reduction in inflammation, necrosis and fibrosis. These results were in accordance with liver histology analysis, liver comet assay, and changes in serum levels of ALT, AST, and AP. The changes observed in gut microbiome support detrimental effects of TAA and hepatoprotective effects of low C60 dose. Less protective effects of a higher C60 dose could be a consequence of its enhanced aggregation and related pro-oxidant role.